Actavis boosts antibiotics with Durata buyout
Wednesday, October 8, 2014 - 07:50
in Health & Medicine
$820 million deal gives Actavis control of newly-approved intravenous antibiotic
$820 million deal gives Actavis control of newly-approved intravenous antibiotic